Extended-release (ER) drugs are the formulations designed to release the drug slowly over a long period, so that the therapeutic effect lasts longer and the medicine can be taken less frequently (often once daily). They help to maintain a more constant drug level in the blood. The duration of action lasts longer (12-24 hours).
Example:
Metformin ER
Diclofenac ER
Paracetamol ER
Sustained-release (SR) drugs are the formulations that release the drug gradually at a controlled rate to sustain the drug concentration in the blood for a longer time than immediate-release forms, but usually for a shorter duration (8-12 hours) than ER formulations. The dosing frequency is usually twice daily.
Example:
Diclofenac SR
Theophylline SR
Bupropion SR
Key facts about ER and SR drugs
Both are modified-release formulations.
These formulations have reduced dosing frequency which leads to better adherence.
These help to avoid high peaks(toxicity) and prevent low troughs (los of effect).
It is considered to have improved safety and tolerability.
Some ER/SR formulations show food-dependent absorption.
Extended-release and Sustained-release formulations provide prolonged drug action, improve compliance, reduce side effects, and must not be crushed or chewed.
“How does the choice between ER and SR formulations influence treatment outcomes and patient compliance?”
Choosing between ER and SR formulations directly affects treatment success by balancing steady drug levels with dosing convenience, ultimately improving patient adherence and safety.
The choice between ER and SR formulations influences outcomes by balancing duration of action with dosing convenience, as ER products with once-daily dosing and steadier plasma levels generally improve patient compliance and reduce peak-related side effects, while SR formulations offer flexibility with twice-daily dosing that may better suit drugs or patients requiring moderate control over drug release.